Advanced search
Publication Cover
Renal Failure Volume 34, 2012 - Issue 4
Submit an article Journal homepage
521
Views
9
CrossRef citations to date
0
Altmetric
Clinical Study

Predictors of Changes in Hemoglobin Levels in Patients with Chronic Hepatitis C Treated with Ribavirin Plus Pegylated Interferon-α

Ching-Chih HuLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan;College of Medicine, Chang Gung University, Taoyuan, Taiwan
,
Cheng-Hao WengCollege of Medicine, Chang Gung University, Taoyuan, Taiwan;Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan
,
Chih-Lang LinLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan;College of Medicine, Chang Gung University, Taoyuan, Taiwan
,
Hui-Ching TienLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan
,
Yen-Lin KuoLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan
,
Cheng-Hung ChienLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan
,
Cho-Li YenLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan
,
Chun-Yen LinCollege of Medicine, Chang Gung University, Taoyuan, Taiwan;Liver Research Unit, Chang Gung Memorial Hospital, Linkou, Taiwan
&
Rong-Nan ChienLiver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan;College of Medicine, Chang Gung University, Taoyuan, TaiwanCorrespondence[email protected]
 show all
Pages 429-434 | Received 22 Sep 2011, Accepted 09 Dec 2011, Published online: 23 Jan 2012

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xina Li, Tong Liu, Xin Hai & Le Li. (2021) Interferon-α2b induced anemia in severe coronavirus disease 2019 patients: a single centered, retrospective study. Immunopharmacology and Immunotoxicology 43:6, pages 644-650.
Read now

Articles from other publishers (8)

Sheng-Lei Yan, Cheng-Shyong Chang, Chien-Hua Chen, Yung-Hsiang Yeh & Chien-Yu Tsai. (2016) Reticulocyte production index as a predictor of clinically significant anemia in chronic hepatitis C patients receiving pegylated interferon combination therapy. Advances in Digestive Medicine 3:1, pages 18-23.
Crossref
N. Miotto, L.C. Mendes, L.P. Zanaga, E.S.L. Goncales, M.S.K. Lazarini, M.N. Pedro, F.L. Goncales Jr., R.S.B. Stucchi & A.G. Vigani. (2016) Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors. Brazilian Journal of Medical and Biological Research 49:7.
Crossref
Ching-Chih Hu, Chih-Lang Lin, Liang-Che Chang, Cheng-Hung Chien, Li-Wei Chen, Ching-Jung Liu & Rong-Nan Chien. (2015) Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study. BMC Infectious Diseases 15:1.
Crossref
Laurent Cotte, Aurélie Barrail-Tran, Corine Vincent, Marc-Antoine Valantin, Isabelle Fournier, Karine Lacombe, Stéphane Chevaliez, Jean-Pierre Aboulker, Anne-Marie Taburet & Jean-Michel Molina. (2014) Telaprevir Enhances Ribavirin-Induced Anaemia through Renal Function Impairment. Antiviral Therapy 20:5, pages 479-486.
Crossref
Sheng Hung Chen, Cheng Yuan Peng, Hsueh Chou Lai, Wen Pang Su, Chia Hsin Lin, Yu Fen Li, Po Heng Chuang & Ching Hsiang Chen. (2015) An Index to Predict Ribavirin-Induced Anemia in Asian Patients With Chronic Genotype 1 Hepatitis C. Hepatitis Monthly 15:3.
Crossref
James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich & Andrea D. Branch. (2014) Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver International 34:7, pages 1018-1024.
Crossref
Lauren M Hynicka & Emily L Heil. (2013) Anemia Management in Patients with Chronic Viral Hepatitis C. Annals of Pharmacotherapy 47:2, pages 228-236.
Crossref
M. Palmer, R. Rubin & V. Rustgi. (2012) Randomised clinical trial: pre‐dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment‐naïve patients with chronic hepatitis C genotype 1. Alimentary Pharmacology & Therapeutics 36:4, pages 370-378.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.